At a glance
The CLIAC Biosafety Workgroup is charged with providing input to CLIAC for consideration in making recommendations to the Department of Health and Human Services (HHS) on the potential additions to the CLIA regulations.
Overview
The CLIAC Biosafety Workgroup is charged with providing input to CLIAC for consideration in making recommendations to the Department of Health and Human Services (HHS) on the potential additions to the CLIA regulations and the need for solutions that will improve the safety of laboratory professionals, their colleagues, and the environment.
Officers and members
Chair
Michael A. Pentella, PhD, MS, SM(ASCP), CIC, D(ABMM)
Director, Iowa State Hygienic Laboratory
Clinical Professor
University of Iowa
Coralville, IA
Designated Federal Officer
Víctor R. De Jesús, PhD
Chief, Quality and Safety Systems Branch
Division of Laboratory Systems
Office of Laboratory Science and Safety
Centers for Disease Control and Prevention
Ex Officio Members
Nancy Cornish, MD
Medical Officer
Quality and Safety Systems Branch
Division of Laboratory Systems
Office of Laboratory Science and Safety
Centers for Disease Control and Prevention
Lane N. Vause, MS, MPH, MLS(ASCP)MBCM CPH
Commander, United States Public Health Service
Laboratory Consultant, CLIA program
Division of Clinical Laboratory Improvement and Quality
Centers for Medicare & Medicaid Services
Amy Zale, MT(ASCP)
Director, Division of Program Operations and Management
Office of In Vitro Diagnostics
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Food and Drug Administration